These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1325 related articles for article (PubMed ID: 32745596)

  • 1. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.
    Musuuza JS; Watson L; Parmasad V; Putman-Buehler N; Christensen L; Safdar N
    PLoS One; 2021; 16(5):e0251170. PubMed ID: 33956882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
    De Francesco MA; Signorini L; Piva S; Pellizzeri S; Fumarola B; Corbellini S; Piccinelli G; Simonetti F; Carta V; Mangeri L; Padovani M; Vecchiati D; Latronico N; Castelli F; Caruso A
    J Med Virol; 2023 Jul; 95(7):e28892. PubMed ID: 37394790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
    Liu HH; Yaron D; Piraino AS; Kapelusznik L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.
    Nebreda-Mayoral T; Miguel-Gómez MA; March-Rosselló GA; Puente-Fuertes L; Cantón-Benito E; Martínez-García AM; Muñoz-Martín AB; Orduña-Domingo A
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Apr; 40(4):158-165. PubMed ID: 35216948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
    Falcone M; Tiseo G; Giordano C; Leonildi A; Menichini M; Vecchione A; Pistello M; Guarracino F; Ghiadoni L; Forfori F; Barnini S; Menichetti F;
    J Antimicrob Chemother; 2021 Mar; 76(4):1078-1084. PubMed ID: 33374002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
    Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infection pathogen analysis of 2388 patients in an open hematology ward from 1993 to 2004].
    Han B; Di HX; Zhou DB; Zhao YQ; Wang SJ; Xu Y; Chen JL; Duan Y; Jiao L; Duan MH; Zhang W; Zhu TN; Zou N; Shen T
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):664-8. PubMed ID: 16681921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What happened during COVID-19 in African ICUs? An observational study of pulmonary co-infections, superinfections, and mortality in Morocco.
    Aissaoui Y; Ennassimi Y; Myatt I; El Bouhiaoui M; Nabil M; Bahi M; Arsalane L; Miloudi M; Belhadj A
    PLoS One; 2022; 17(12):e0278175. PubMed ID: 36454978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the role of bacterial and fungal infection in COVID-19.
    Rawson TM; Wilson RC; Holmes A
    Clin Microbiol Infect; 2021 Jan; 27(1):9-11. PubMed ID: 32979569
    [No Abstract]   [Full Text] [Related]  

  • 13. Superinfection during treatment of nosocomial infections with tigecycline.
    García-Cabrera E; Jiménez-Mejías ME; Gil Navarro MV; Gómez-Gómez MJ; Ortiz-Leyba C; Cordero E; Pachón J;
    Eur J Clin Microbiol Infect Dis; 2010 Jul; 29(7):867-71. PubMed ID: 20473700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 15. Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico.
    García-Salazar E; Benavidez-López S; Bonifaz A; Hernández-Mendoza EA; Ramírez-Magaña X; Reyes-Montes MDR; Duarte-Escalante E; Acosta-Altamirano G; Frías-De-León MG
    Biomedica; 2024 Aug; 44(3):328-339. PubMed ID: 39241240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
    Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
    BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
    Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
    Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial infections and outcomes of inpatients with COVID-19 in the intensive care unit during the delta-dominant phase: the worst wave of pandemic in Iran.
    Akbari M; Dehghani Y; Shirzadi M; Pourajam S; Hosseinzadeh M; Sajadi M; Alenaseri M; Siavash M; Jafari L; Solgi H
    Front Public Health; 2024; 12():1411314. PubMed ID: 39314786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
    Chen Z; Zhan Q; Huang L; Wang C
    Front Public Health; 2023; 11():1195048. PubMed ID: 37711242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.